- Myōan
Eisai/Yōsai (明菴栄西, 27 May 1141 – 1
August 1215) was a ****anese
Buddhist priest,
credited with
founding the
Rinzai school, the ****anese line of the...
-
Eisai Co., Ltd. (****anese: エーザイ株式会社, Hepburn: Ēzai Kabushiki-gaisha) is a ****anese
pharmaceutical company headquartered in Tokyo, ****an. It has some 10...
- Alzheimer's
disease to
reduce its buildup. It was
developed by
Biogen and
Eisai.
Aducanumab is
given via
intravenous infusion.
Aducanumab was
approved for...
-
Eisai I
Mousiki Mou (Gr****: Είσαι η Μουσική Μου;
English language: You are My Music) is the
second studio album by Gr**** pop
singer Natalia. It was released...
-
class of
antibodies targeting amyloid.
Lecanemab was
jointly developed by
Eisai and Biogen. It was
granted accelerated approval for
medical use in the United...
- next-day
effects such as
daytime somnolence with lemborexant. In June 2016,
Eisai initiated Phase III
clinical trials in the
United States, France, Germany...
-
Eisai, and no do****ents have been
found to
indicate whether those words were
introduced to ****an and
changed to
matcha by the 16th century.
Eisai's disciple...
-
Research leading to the
development of
donepezil began in 1983, at
Eisai, and in 1996,
Eisai received approval from the
United States Food and Drug Administration...
- Zonegran,
before Élan
transferred their interests in
zonisamide to
Eisai Co., Ltd. in 2004.
Eisai also
markets Zonegran in Asia (China, Taiwan, and
fourteen others)...
- was
making along with
Eisai. In
October 2019, however, they
announced that they
would pursue FDA
approval together with
Eisai. On
October 22, 2019, despite...
